Human PAFAH2(Platelet Activating Factor Acetylhydrolase 2) ELISA Kit from ELK Biotechnology Read more ›
Human PAFAH2(Platelet Activating Factor Acetylhydrolase 2) ELISA Kit is a research-use ELISA kit from ELK Biotechnology for measuring PAFAH2 in Plasma samples from Human. Use the listed assay range, sample guidance and protocol documents to assess suitability for the intended study.
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human PAFAH2. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human PAFAH2. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human PAFAH2, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human PAFAH2 in the samples is then determined by comparing the OD of the samples to the standard curve.
Alternative names include SD-PLA2; Serine-dependent phospholipase A2; Platelet-activating factor acetylhydrolase 2, cytoplasmic.
| Collaborator | ELK Biotechnology |
| Partner model | ELK1780 |
| Target | PAFAH2 |
| Research areas | Enzyme & Kinase, Metabolic pathway, Hematology |
| Reactivity | Human |
| Applications | ELISA |
| Assay type | Sandwich |
| Sample types | Plasma |
| Detection range | 0.32-20 ng/mL |
| Sensitivity | 0.1 ng/mL |
| Sample Type | SERUM | PLASMA (EDTA) | URINE | CSF | CELL SUPERNATANT |
|---|---|---|---|---|---|
| Sample compatibility |
Collaborator meets ABMIUM quality standards and overall product performance standards have been met.
Quality management certification.
For research applications. Not for diagnostic use.
No customer reviews yet.
